Figure 7.

Linear fit of change from Baseline at Day 90 in ADAS-Cog score and log transformed
post-dose serum BHB levels in the per protocol population stratified by APOE4 carriage
status. Red symbols represent subjects taking AC-1202. Blue symbols represent subjects taking
Placebo. Circles and squares indicate dosage compliant subjects, crosses represent
non-compliant subjects. The solid lines represent the linear fit in the per protocol
population. The dashed lines represent the linear fit in the dosage compliant sub-population
of the per protocol population. A) A significant correlation was found in the per protocol population between serum BHB
levels and change in ADAS-Cog on Day 90. B) A significant correlation was found in E4(-) per protocol subjects between serum BHB
levels and change in ADAS-Cog on Day 90. C) No significant correlation was found in E4(+) per protocol subjects between serum
BHB levels and change in ADAS-Cog on Day 90. In each case the linear fit of the dosage
compliant subgroup is very similar to the overall per protocol population.